Hospital Kulim

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• University of Sydney1 trial

Running trials

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

  NCT02823821· Phase 4· University of Sydney· Source

  Contact: Grace Balicki

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting